Eurogentec enters in the Therapeutic Oligonucleotides Manufacturing Field

Products & Services

Combining over 30 years of expertise in oligonucleotide synthesis to 20 years of biopharmaceutical GMP manufacturing, we now offer GMP therapeutic oligonucleotides manufacturing for early clinical phases.

GMP certification by the Belgium Authorities for the manufacturing and quality control of therapeutic oligonucleotides according to ICH Q7 is planned for Q1 2019.

 

 

Attached Files

Trending Now

University of Louvain bacteria research appeals to Japan

Next post

Recommended for you

15-17 October 2025

Bioplus Interphex

Seoul, South Korea

Let's meet at "Bioplus Interphex"

@ Seoul, South Korea
📅October 15-17, 2025
📍Seoul, South Korea - Kaneka Corporation's booth H16...
Continue Reading
11-14 May 2026

TIDES USA 2026

Boston, MA, USA

Eurogentec at "TIDES USA 2026"

@ Boston, MA, USA
📅May 11-14, 2026
📍Boston (USA) - Booth #800...
Continue Reading
22-25 June 2026

BIO 2026

San Diego, CA, USA

Meet us at "BIO International Convention 20..

@ San Diego, CA, USA
📅June 22-25, 2026
📍San Diego, USA - Booth #5451...
Continue Reading